For the first time, the Food and Drug Administration has issued a warning urging healthcare organizations to discontinue the use of a family of medical devices due to cybersecurity issues and transition to other products.
In a July 31 safety communication, the FDA says healthcare providers using the Hospira Symbiq Infusion System, Version 3.13 or older, are "strongly encouraged" to transition to alternative infusion systems and discontinue use of these pumps due to cybersecurity vulnerabilities.
"Hospira and an independent researcher confirmed that Hospira's Symbiq Infusion System could be accessed remotely through a hospital's network," the FDA notes in its statement.
Read more: http://www.healthcareinfosecurity.com/fda-discontinue-use-flawed-infusion-pumps-a-8449
Comments